Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Eyegate Pharmaceuticals Inc. EYEGV

Healthcare Biotechnology

Recent & Breaking News (GREY:EYEGV)

Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients

PR Newswire February 21, 2017

EyeGate Pharmaceuticals Announces Executive Promotions

GlobeNewswire February 6, 2017

15 Biggest Mid-Day Gainers For Monday

Benzinga.com  January 30, 2017

Mid-Day Market Update: Dow Falls Over 150 Points; Calithera Biosciences Shares Spike Higher

Benzinga.com  January 30, 2017

Mid-Morning Market Update: Markets Open Lower; Booz Allen Profit Misses Estimates

Benzinga.com  January 30, 2017

EyeGate Pharma Announces Positive Top-line Data from First-in-Human Pilot Trial of Ocular Bandage Gel in Corneal Epithelial Defects

GlobeNewswire January 30, 2017

EyeGate Pharmaceuticals to Present at the Noble Financial Capital Markets’ 13th Annual Investor Conference

GlobeNewswire January 24, 2017

EyeGate Pharma Awarded Canadian Patent for Proprietary Iontophoretic Formulation and Use of the Formulation for Ocular Delivery of Dexamethasone Phosphate

GlobeNewswire January 23, 2017

EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437

GlobeNewswire January 9, 2017

EyeGate Reports Positive Data from Third Stage of Phase 1b/2a Clinical Trial of EGP-437 in Cataract Surgery Patients

GlobeNewswire December 5, 2016

Recro Pharma CEO Discusses Strong Results In Non-Opioid Pain Treatment Study

Benzinga.com  December 1, 2016

15 Biggest Mid-Day Gainers For Friday

Benzinga.com  November 18, 2016

Mid-Day Market Update: Abercrombie & Fitch Drops After Downbeat Earnings; Synutra Shares Spike Higher

Benzinga.com  November 18, 2016

Mid-Morning Market Update: Markets Mostly Flat; Foot Locker Profit Beats Estimates

Benzinga.com  November 18, 2016

FDA Confirms a 510(k) De Novo Path for EyeGate’s Device, the Ocular Bandage Gel, Following Pre-Submission Meeting

GlobeNewswire November 17, 2016

EyeGate Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update

GlobeNewswire November 2, 2016

EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital Conference

GlobeNewswire September 21, 2016

EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of Defense

GlobeNewswire September 13, 2016

EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437

GlobeNewswire September 12, 2016

EyeGate Pharmaceuticals to Present at the 18th Annual Rodman and Renshaw Global Investment Conference

GlobeNewswire September 6, 2016